Demographic data of the study population (n=44)
| Sex | n (%) |
| Male | 34 (77%) |
| Female | 10 (23%) |
| Age | Years, mean (SD) |
| Male | 9.12 (1.87) |
| Female | 9.16 (1.92) |
| Age group16 | n (%) |
| Infants and toddlers (1–5 years) | 1 (2%)* |
| Children (6–13 years) | 39 (89%) |
| Adolescents (14–18 years) | 4 (9%) |
| BMI group | n (%) |
| Underweight (≥P3 and <P10) | 2 (5%) |
| Normal weight (≥P10 and <P90) | 34 (77%) |
| Overweight (≥P90 and <P97) | 2 (5%) |
| Obesity (≥P97) | 6 (13%) |
*One child younger than 6 years was included in the NIS, but approval for MPH therapy was obtained after the child’s sixth birthday; therefore, it was not started until after age 6 years.
BMI, body mass index; MPH, methylphenidate hydrochloride; NIS, non-interventional study; P, percentile of body mass index.